These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 24477283)
1. Isolation and characterization of anti-adenoviral secondary metabolites from marine actinobacteria. Strand M; Carlsson M; Uvell H; Islam K; Edlund K; Cullman I; Altermark B; Mei YF; Elofsson M; Willassen NP; Wadell G; Almqvist F Mar Drugs; 2014 Jan; 12(2):799-821. PubMed ID: 24477283 [TBL] [Abstract][Full Text] [Related]
2. [Secondary Metabolites from Marine Microorganisms. I. Secondary Metabolites from Marine Actinomycetes]. Orlova TI; Bulgakova VG; Polin AN Antibiot Khimioter; 2015; 60(7-8):47-59. PubMed ID: 26863742 [TBL] [Abstract][Full Text] [Related]
3. Pharmaceutically active secondary metabolites of marine actinobacteria. Manivasagan P; Venkatesan J; Sivakumar K; Kim SK Microbiol Res; 2014 Apr; 169(4):262-78. PubMed ID: 23958059 [TBL] [Abstract][Full Text] [Related]
4. In vitro anti-adenoviral activities of ethanol extract, fractions, and main phenolic compounds of pomegranate ( Karimi A; Moradi MT; Rabiei M; Alidadi S Antivir Chem Chemother; 2020; 28():2040206620916571. PubMed ID: 32306749 [TBL] [Abstract][Full Text] [Related]
5. Inhibitors of metalloprotease, γ-sectretase, protein kinase C and Rho kinase inhibit wild-type adenoviral replication. Liu A; Ildefonso CJ; Bond WS; Hurwitz MY; Hurwitz RL PLoS One; 2020; 15(7):e0236175. PubMed ID: 32697798 [TBL] [Abstract][Full Text] [Related]
6. Longitudinal Monitoring of the Effects of Anti-Adenoviral Treatment Regimens in a Permissive In Vivo Model. Tollefson AE; Cline-Smith A; Spencer JF; Ying B; Reyna DM; Lipka E; James SH; Toth K Viruses; 2024 Jul; 16(8):. PubMed ID: 39205174 [TBL] [Abstract][Full Text] [Related]
7. [Povidone-iodine for treatment of adenoviral conjunctivitis: an in vitro study]. Monnerat N; Bossart W; Thiel MA Klin Monbl Augenheilkd; 2006 May; 223(5):349-52. PubMed ID: 16705502 [TBL] [Abstract][Full Text] [Related]
8. Marine Actinomycetes-derived Natural Products. Yang C; Qian R; Xu Y; Yi J; Gu Y; Liu X; Yu H; Jiao B; Lu X; Zhang W Curr Top Med Chem; 2019; 19(31):2868-2918. PubMed ID: 31724505 [TBL] [Abstract][Full Text] [Related]
9. Marine actinomycetes as an emerging resource for the drug development pipelines. Zotchev SB J Biotechnol; 2012 Apr; 158(4):168-75. PubMed ID: 21683100 [TBL] [Abstract][Full Text] [Related]
10. Antiadenoviral effect of the alpha 5 beta 1 integrin receptor ligand, GRGDSP peptide, in serotypes that cause acute keratoconjunctivitis. Uchio E; Kimura R; Huang YH; Fuchigami A; Kadonosono K; Hayashi A; Ishiko H; Aoki K; Ohno S Ophthalmologica; 2007; 221(5):326-30. PubMed ID: 17728555 [TBL] [Abstract][Full Text] [Related]
11. The In Vitro Evaluation of Povidone-Iodine Against Multiple Ocular Adenoviral Types. Yates KA; Shanks RMQ; Kowalski RP; Romanowski EG J Ocul Pharmacol Ther; 2019 Mar; 35(2):132-136. PubMed ID: 30589605 [TBL] [Abstract][Full Text] [Related]
12. Phenyl phosphoramidate derivatives of stavudine as anti-HIV agents with potent and selective in-vitro antiviral activity against adenovirus. Uckun FM; Pendergrass S; Qazi S; Samuel P; Venkatachalam TK Eur J Med Chem; 2004 Mar; 39(3):225-34. PubMed ID: 15051170 [TBL] [Abstract][Full Text] [Related]
13. Bioactive terpenes from marine-derived fungi. Elissawy AM; El-Shazly M; Ebada SS; Singab AB; Proksch P Mar Drugs; 2015 Apr; 13(4):1966-92. PubMed ID: 25854644 [TBL] [Abstract][Full Text] [Related]
14. Medicinal Purposes: Bioactive Metabolites from Marine-derived Organisms. Li T; Ding T; Li J Mini Rev Med Chem; 2019; 19(2):138-164. PubMed ID: 28969543 [TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of local ocular toxicity in candidate anti-adenoviral agents in vivo. Inoue H; Sonoda KH; Ishikawa M; Kadonosono K; Uchio E Ophthalmologica; 2009; 223(4):233-8. PubMed ID: 19262070 [TBL] [Abstract][Full Text] [Related]